Synonyms: | |
Status: | Approved (1995) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | V03AF02 |
UNII: | 048L81261F |
InChI Key | BMKDZUISNHGIBY-ZETCQYMHSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C11H16N4O4 |
Molecular Weight | 268.27 |
AlogP | -2.71 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 98.82 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 19.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | DNA topoisomerase II inhibitor | EMA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hepatoblastoma | 3 | D018197 | ClinicalTrials |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
Rhabdomyosarcoma | 2 | D012208 | ClinicalTrials |
Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
Neuroblastoma | 2 | D009447 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Sarcoma, Ewing | 2 | D012512 | ClinicalTrials |
Ganglioneuroblastoma | 2 | D018305 | ClinicalTrials |
Heart Defects, Congenital | 1 | D006330 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Osteosarcoma | 1 | D012516 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 24584-09-6 |
ChEBI | 50223 |
ChEMBL | CHEMBL1738 |
DrugBank | DB00380 |
DrugCentral | 839 |
EPA CompTox | DTXSID3040647 |
FDA SRS | 048L81261F |
Human Metabolome Database | HMDB0014524 |
Guide to Pharmacology | 7330 |
PharmGKB | PA449259 |
PubChem | 71384 |
SureChEMBL | SCHEMBL18400 |
ZINC | ZINC000087515509 |